These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 29654096)

  • 1. Cost-effectiveness of cardiac rehabilitation: a systematic review.
    Shields GE; Wells A; Doherty P; Heagerty A; Buck D; Davies LM
    Heart; 2018 Sep; 104(17):1403-1410. PubMed ID: 29654096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of home-based cardiac rehabilitation: a systematic review.
    Shields GE; Rowlandson A; Dalal G; Nickerson S; Cranmer H; Capobianco L; Doherty P
    Heart; 2023 May; 109(12):913-920. PubMed ID: 36849233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.
    Picot J; Jones J; Colquitt JL; Gospodarevskaya E; Loveman E; Baxter L; Clegg AJ
    Health Technol Assess; 2009 Sep; 13(41):1-190, 215-357, iii-iv. PubMed ID: 19726018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-Effectiveness of Exercise-Based Cardiac Rehabilitation in Chilean Patients Surviving Acute Coronary Syndrome.
    Serón P; Gaete M; Oliveros MJ; Román C; Lanas F; Velásquez M; Reveco R; Bustos L; Rojas R
    J Cardiopulm Rehabil Prev; 2019 May; 39(3):168-174. PubMed ID: 31021998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review of economic evaluations of cardiac rehabilitation.
    Wong WP; Feng J; Pwee KH; Lim J
    BMC Health Serv Res; 2012 Aug; 12():243. PubMed ID: 22873828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
    Shepherd J; Jones J; Takeda A; Davidson P; Price A
    Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
    Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
    Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supported self-management for patients with moderate to severe chronic obstructive pulmonary disease (COPD): an evidence synthesis and economic analysis.
    Jordan RE; Majothi S; Heneghan NR; Blissett DB; Riley RD; Sitch AJ; Price MJ; Bates EJ; Turner AM; Bayliss S; Moore D; Singh S; Adab P; Fitzmaurice DA; Jowett S; Jolly K
    Health Technol Assess; 2015 May; 19(36):1-516. PubMed ID: 25980984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Which interventions are cost-effective for the management of whiplash-associated and neck pain-associated disorders? A systematic review of the health economic literature by the Ontario Protocol for Traffic Injury Management (OPTIMa) Collaboration.
    van der Velde G; Yu H; Paulden M; Côté P; Varatharajan S; Shearer HM; Wong JJ; Randhawa K; Southerst D; Mior S; Sutton D; Jacobs C; Taylor-Vaisey A
    Spine J; 2016 Dec; 16(12):1582-1597. PubMed ID: 26631759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ecologically optimizing exercise maintenance in men and women post-cardiac rehabilitation: Protocol for a randomized controlled trial of efficacy with economics (ECO-PCR).
    Reid R; Blanchard CM; Wooding E; Harris J; Krahn M; Pipe A; Chessex C; Grace SL
    Contemp Clin Trials; 2016 Sep; 50():116-23. PubMed ID: 27475772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EU-CaRE study: Could exercise-based cardiac telerehabilitation also be cost-effective in elderly?
    Scherrenberg M; Zeymer U; Schneider S; Van der Velde AE; Wilhelm M; Van't Hof AWJ; Kolkman E; Prins LF; Prescott E; Iliou MC; Peña-Gil C; Ardissino D; De Kluiver EP; Dendale P
    Int J Cardiol; 2021 Oct; 340():1-6. PubMed ID: 34419529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
    Main C; Bojke L; Griffin S; Norman G; Barbieri M; Mather L; Stark D; Palmer S; Riemsma R
    Health Technol Assess; 2006 Mar; 10(9):1-132. iii-iv. PubMed ID: 16545208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppressive therapy for kidney transplantation in children and adolescents: systematic review and economic evaluation.
    Haasova M; Snowsill T; Jones-Hughes T; Crathorne L; Cooper C; Varley-Campbell J; Mujica-Mota R; Coelho H; Huxley N; Lowe J; Dudley J; Marks S; Hyde C; Bond M; Anderson R
    Health Technol Assess; 2016 Aug; 20(61):1-324. PubMed ID: 27557331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cost-effectiveness of exercise-based cardiac telerehabilitation intervention: a systematic review.
    Batalik L; Filakova K; Sladeckova M; Dosbaba F; Su J; Pepera G
    Eur J Phys Rehabil Med; 2023 Apr; 59(2):248-258. PubMed ID: 36692413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cardiac telerehabilitation in patients with coronary artery disease using a personalised patient-centred web application: protocol for the SmartCare-CAD randomised controlled trial.
    Brouwers RW; Kraal JJ; Traa SC; Spee RF; Oostveen LM; Kemps HM
    BMC Cardiovasc Disord; 2017 Jan; 17(1):46. PubMed ID: 28143388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy (including a review of TA140 and TA262): clinical effectiveness systematic review and economic model.
    Archer R; Tappenden P; Ren S; Martyn-St James M; Harvey R; Basarir H; Stevens J; Carroll C; Cantrell A; Lobo A; Hoque S
    Health Technol Assess; 2016 May; 20(39):1-326. PubMed ID: 27220829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab for the first-line treatment of stage III-IV follicular lymphoma (review of Technology Appraisal No. 110): a systematic review and economic evaluation.
    Papaioannou D; Rafia R; Rathbone J; Stevenson M; Buckley Woods H; Stevens J
    Health Technol Assess; 2012; 16(37):1-253, iii-iv. PubMed ID: 23021127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical effectiveness and cost-effectiveness of beta-interferon and glatiramer acetate for treating multiple sclerosis: systematic review and economic evaluation.
    Melendez-Torres GJ; Auguste P; Armoiry X; Maheswaran H; Court R; Madan J; Kan A; Lin S; Counsell C; Patterson J; Rodrigues J; Ciccarelli O; Fraser H; Clarke A
    Health Technol Assess; 2017 Sep; 21(52):1-352. PubMed ID: 28914229
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.